APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nanomedicine Manufacturing Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nanomedicine Manufacturing Services Industry Growth and Trends Forecast to 2032

Report ID 17419542011 January 2026102 pages

Choose your research edition.

Industry ResearchNanomedicine Manufacturing Services Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanomedicine Manufacturing Services Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Nanomedicine Manufacturing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanomedicine Manufacturing Services Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanomedicine Manufacturing Services Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Nanomedicine Manufacturing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nanomedicine Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nanomedicine Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nanomedicine Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Nanomedicine Manufacturing Services market include nanoComposix, Ardena Nanomedicines, Cytiva, Inside Therapeutics, Fortis Life Sciences, AstraZeneca, Ascendia Pharmaceuticals, Axolabs and AVANSA Technology & Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nanomedicine Manufacturing Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nanomedicine Manufacturing Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nanomedicine Manufacturing Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nanomedicine Manufacturing Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Nanomedicine Manufacturing Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nanomedicine Manufacturing Services Market by Company

nanoComposix

Ardena Nanomedicines

Cytiva

Inside Therapeutics

Fortis Life Sciences

AstraZeneca

Ascendia Pharmaceuticals

Axolabs

AVANSA Technology & Services

MyBiotech

Nanochemazone

TechNanoIndia

Encapsula NanoSciences

STA Pharmaceutical Co. Ltd.

Nanomedicine Manufacturing Services Segment by Type

Nanocarrier Construction

Drug Production

Quality Testing

Process Development

Nanomedicine Manufacturing Services Segment by Application

Cancer

Cardiovascular Disease

Nervous System Disease

Infectious Disease

Others

Nanomedicine Manufacturing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanomedicine Manufacturing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanomedicine Manufacturing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanomedicine Manufacturing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Nanomedicine Manufacturing Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Nanomedicine Manufacturing Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Nanomedicine Manufacturing Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Nanomedicine Manufacturing Services Market Share by Region (2021-2026) Table 4. Global Nanomedicine Manufacturing Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Nanomedicine Manufacturing Services Market Share by Region (2027-2032) Table 6. Global Nanomedicine Manufacturing Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Nanomedicine Manufacturing Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Nanomedicine Manufacturing Services Market Size Share by Type (2021-2026) Table 9. Global Nanomedicine Manufacturing Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Nanomedicine Manufacturing Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Nanomedicine Manufacturing Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Nanomedicine Manufacturing Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Nanomedicine Manufacturing Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Nanomedicine Manufacturing Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Nanomedicine Manufacturing Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Nanomedicine Manufacturing Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Nanomedicine Manufacturing Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Nanomedicine Manufacturing Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Nanomedicine Manufacturing Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Nanomedicine Manufacturing Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Nanomedicine Manufacturing Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Nanomedicine Manufacturing Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Nanomedicine Manufacturing Services Market Size Share by Application (2021-2026) Table 24. Global Nanomedicine Manufacturing Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Nanomedicine Manufacturing Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Nanomedicine Manufacturing Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Nanomedicine Manufacturing Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Nanomedicine Manufacturing Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Nanomedicine Manufacturing Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Nanomedicine Manufacturing Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Nanomedicine Manufacturing Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Nanomedicine Manufacturing Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Nanomedicine Manufacturing Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Nanomedicine Manufacturing Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Nanomedicine Manufacturing Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Nanomedicine Manufacturing Services Industry Trends Table 37. Nanomedicine Manufacturing Services Industry Drivers Table 38. Nanomedicine Manufacturing Services Industry Opportunities and Challenges Table 39. Nanomedicine Manufacturing Services Industry Restraints Table 40. Global Nanomedicine Manufacturing Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Nanomedicine Manufacturing Services Revenue Market Share by Company (2021-2026) Table 42. Global Nanomedicine Manufacturing Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Nanomedicine Manufacturing Services Key Company Headquarters & Area Served Table 44. Global Nanomedicine Manufacturing Services Company, Product Type & Application Table 45. Global Nanomedicine Manufacturing Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Nanomedicine Manufacturing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. nanoComposix Company Information Table 49. nanoComposix Business Overview Table 50. nanoComposix Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. nanoComposix Nanomedicine Manufacturing Services Product Portfolio Table 52. nanoComposix Recent Development Table 53. Ardena Nanomedicines Company Information Table 54. Ardena Nanomedicines Business Overview Table 55. Ardena Nanomedicines Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Ardena Nanomedicines Nanomedicine Manufacturing Services Product Portfolio Table 57. Ardena Nanomedicines Recent Development Table 58. Cytiva Company Information Table 59. Cytiva Business Overview Table 60. Cytiva Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Cytiva Nanomedicine Manufacturing Services Product Portfolio Table 62. Cytiva Recent Development Table 63. Inside Therapeutics Company Information Table 64. Inside Therapeutics Business Overview Table 65. Inside Therapeutics Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Inside Therapeutics Nanomedicine Manufacturing Services Product Portfolio Table 67. Inside Therapeutics Recent Development Table 68. Fortis Life Sciences Company Information Table 69. Fortis Life Sciences Business Overview Table 70. Fortis Life Sciences Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Fortis Life Sciences Nanomedicine Manufacturing Services Product Portfolio Table 72. Fortis Life Sciences Recent Development Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. AstraZeneca Nanomedicine Manufacturing Services Product Portfolio Table 77. AstraZeneca Recent Development Table 78. Ascendia Pharmaceuticals Company Information Table 79. Ascendia Pharmaceuticals Business Overview Table 80. Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Product Portfolio Table 82. Ascendia Pharmaceuticals Recent Development Table 83. Axolabs Company Information Table 84. Axolabs Business Overview Table 85. Axolabs Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Axolabs Nanomedicine Manufacturing Services Product Portfolio Table 87. Axolabs Recent Development Table 88. AVANSA Technology & Services Company Information Table 89. AVANSA Technology & Services Business Overview Table 90. AVANSA Technology & Services Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. AVANSA Technology & Services Nanomedicine Manufacturing Services Product Portfolio Table 92. AVANSA Technology & Services Recent Development Table 93. MyBiotech Company Information Table 94. MyBiotech Business Overview Table 95. MyBiotech Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. MyBiotech Nanomedicine Manufacturing Services Product Portfolio Table 97. MyBiotech Recent Development Table 98. Nanochemazone Company Information Table 99. Nanochemazone Business Overview Table 100. Nanochemazone Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Nanochemazone Nanomedicine Manufacturing Services Product Portfolio Table 102. Nanochemazone Recent Development Table 103. TechNanoIndia Company Information Table 104. TechNanoIndia Business Overview Table 105. TechNanoIndia Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. TechNanoIndia Nanomedicine Manufacturing Services Product Portfolio Table 107. TechNanoIndia Recent Development Table 108. Encapsula NanoSciences Company Information Table 109. Encapsula NanoSciences Business Overview Table 110. Encapsula NanoSciences Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Encapsula NanoSciences Nanomedicine Manufacturing Services Product Portfolio Table 112. Encapsula NanoSciences Recent Development Table 113. STA Pharmaceutical Co. Ltd. Company Information Table 114. STA Pharmaceutical Co. Ltd. Business Overview Table 115. STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Product Portfolio Table 117. STA Pharmaceutical Co. Ltd. Recent Development Table 118. North America Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Nanomedicine Manufacturing Services Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Nanomedicine Manufacturing Services Market Share by Country (2021-2026) Table 121. North America Nanomedicine Manufacturing Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Nanomedicine Manufacturing Services Market Share Forecast by Country (2027-2032) Table 123. Europe Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Nanomedicine Manufacturing Services Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Nanomedicine Manufacturing Services Market Share by Country (2021-2026) Table 126. Europe Nanomedicine Manufacturing Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Nanomedicine Manufacturing Services Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Nanomedicine Manufacturing Services Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Nanomedicine Manufacturing Services Market Share by Country (2021-2026) Table 131. Asia-Pacific Nanomedicine Manufacturing Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Nanomedicine Manufacturing Services Market Share Forecast by Country (2027-2032) Table 133. Latin America Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Nanomedicine Manufacturing Services Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Nanomedicine Manufacturing Services Market Share by Country (2021-2026) Table 136. Latin America Nanomedicine Manufacturing Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Nanomedicine Manufacturing Services Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Nanomedicine Manufacturing Services Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Nanomedicine Manufacturing Services Market Share by Country (2021-2026) Table 141. Middle East & Africa Nanomedicine Manufacturing Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Nanomedicine Manufacturing Services Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Nanomedicine Manufacturing Services Product Image Figure 3. Global Nanomedicine Manufacturing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Nanomedicine Manufacturing Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Nanomedicine Manufacturing Services Market Share by Region: 2025 VS 2032 Figure 6. Global Nanomedicine Manufacturing Services Market Share by Region (2021-2032) Figure 7. North America Nanomedicine Manufacturing Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Nanomedicine Manufacturing Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Nanomedicine Manufacturing Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Nanomedicine Manufacturing Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Nanomedicine Manufacturing Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Nanocarrier Construction Image Figure 13. Global Nanocarrier Construction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Drug Production Image Figure 15. Global Drug Production Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Quality Testing Image Figure 17. Global Quality Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Process Development Image Figure 19. Global Process Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Nanomedicine Manufacturing Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Nanomedicine Manufacturing Services Market Share by Type 2025 VS 2032 Figure 22. North America Nanomedicine Manufacturing Services Market Size Share by Type (2021-2032) Figure 23. Europe Nanomedicine Manufacturing Services Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Nanomedicine Manufacturing Services Market Size Share by Type (2021-2032) Figure 25. Latin America Nanomedicine Manufacturing Services Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Nanomedicine Manufacturing Services Market Size Share by Type (2021-2032) Figure 27. Cancer Image Figure 28. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Cardiovascular Disease Image Figure 30. Global Cardiovascular Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Nervous System Disease Image Figure 32. Global Nervous System Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Infectious Disease Image Figure 34. Global Infectious Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Nanomedicine Manufacturing Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Nanomedicine Manufacturing Services Market Share by Application 2025 VS 2032 Figure 39. North America Nanomedicine Manufacturing Services Market Size Share by Application (2021-2032) Figure 40. Europe Nanomedicine Manufacturing Services Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Nanomedicine Manufacturing Services Market Size Share by Application (2021-2032) Figure 42. Latin America Nanomedicine Manufacturing Services Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Nanomedicine Manufacturing Services Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Nanomedicine Manufacturing Services Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Nanomedicine Manufacturing Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Nanomedicine Manufacturing Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Nanomedicine Manufacturing Services Market Share by Country (2021-2032) Figure 49. Europe Nanomedicine Manufacturing Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Nanomedicine Manufacturing Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Nanomedicine Manufacturing Services Market Share by Country (2021-2032) Figure 52. Asia-Pacific Nanomedicine Manufacturing Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Nanomedicine Manufacturing Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Nanomedicine Manufacturing Services Market Share by Country (2021-2032) Figure 55. Latin America Nanomedicine Manufacturing Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Nanomedicine Manufacturing Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Nanomedicine Manufacturing Services Market Share by Country (2021-2032) Figure 58. Middle East & Africa Nanomedicine Manufacturing Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Nanomedicine Manufacturing Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Nanomedicine Manufacturing Services Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Nanocarrier Construction
  • Drug Production
  • Quality Testing
  • Process Development
Applications
  • Cancer
  • Cardiovascular Disease
  • Nervous System Disease
  • Infectious Disease
  • Others
Companies covered
  • nanoComposix
  • Ardena Nanomedicines
  • Cytiva
  • Inside Therapeutics
  • Fortis Life Sciences
  • AstraZeneca
  • Ascendia Pharmaceuticals
  • Axolabs
  • AVANSA Technology & Services
  • MyBiotech
  • Nanochemazone
  • TechNanoIndia
  • Encapsula NanoSciences
  • STA Pharmaceutical Co. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Nanomedicine Manufacturing Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Nanomedicine Manufacturing Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Nanomedicine Manufacturing Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Nanomedicine Manufacturing Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Nanomedicine Manufacturing Services Market Size (2021-2032)
  8. 1.5.1 North America Nanomedicine Manufacturing Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Nanomedicine Manufacturing Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Nanomedicine Manufacturing Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Nanomedicine Manufacturing Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Nanomedicine Manufacturing Services Market Size Growth Rate (2021-2032)
2 Nanomedicine Manufacturing Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Nanocarrier Construction
  3. 2.1.2 Drug Production
  4. 2.1.3 Quality Testing
  5. 2.1.4 Process Development
  6. 2.2 Global Nanomedicine Manufacturing Services Market Size by Type
  7. 2.2.1 Global Nanomedicine Manufacturing Services Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Nanomedicine Manufacturing Services Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Nanomedicine Manufacturing Services Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Nanomedicine Manufacturing Services Market Size by Regions
  11. 2.3.1 North America Nanomedicine Manufacturing Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Nanomedicine Manufacturing Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Nanomedicine Manufacturing Services Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Nanomedicine Manufacturing Services Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Nanomedicine Manufacturing Services Market Size Breakdown by Type (2021-2026)
3 Nanomedicine Manufacturing Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cancer
  3. 3.1.2 Cardiovascular Disease
  4. 3.1.3 Nervous System Disease
  5. 3.1.4 Infectious Disease
  6. 3.1.5 Others
  7. 3.2 Global Nanomedicine Manufacturing Services Market Size by Application
  8. 3.2.1 Global Nanomedicine Manufacturing Services Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Nanomedicine Manufacturing Services Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Nanomedicine Manufacturing Services Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Nanomedicine Manufacturing Services Market Size by Regions
  12. 3.3.1 North America Nanomedicine Manufacturing Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Nanomedicine Manufacturing Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Nanomedicine Manufacturing Services Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Nanomedicine Manufacturing Services Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Nanomedicine Manufacturing Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Nanomedicine Manufacturing Services Industry Trends
  2. 4.2 Nanomedicine Manufacturing Services Industry Drivers
  3. 4.3 Nanomedicine Manufacturing Services Industry Opportunities and Challenges
  4. 4.4 Nanomedicine Manufacturing Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Nanomedicine Manufacturing Services Revenue (2021-2026)
  2. 5.2 Global Nanomedicine Manufacturing Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Nanomedicine Manufacturing Services Key Company Headquarters & Area Served
  4. 5.4 Global Nanomedicine Manufacturing Services Company, Product Type & Application
  5. 5.5 Global Nanomedicine Manufacturing Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Nanomedicine Manufacturing Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Nanomedicine Manufacturing Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Nanomedicine Manufacturing Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 nanoComposix
  2. 6.1.1 nanoComposix Company Information
  3. 6.1.2 nanoComposix Business Overview
  4. 6.1.3 nanoComposix Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 nanoComposix Nanomedicine Manufacturing Services Product Portfolio
  6. 6.1.5 nanoComposix Recent Developments
  7. 6.2 Ardena Nanomedicines
  8. 6.2.1 Ardena Nanomedicines Company Information
  9. 6.2.2 Ardena Nanomedicines Business Overview
  10. 6.2.3 Ardena Nanomedicines Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Ardena Nanomedicines Nanomedicine Manufacturing Services Product Portfolio
  12. 6.2.5 Ardena Nanomedicines Recent Developments
  13. 6.3 Cytiva
  14. 6.3.1 Cytiva Company Information
  15. 6.3.2 Cytiva Business Overview
  16. 6.3.3 Cytiva Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Cytiva Nanomedicine Manufacturing Services Product Portfolio
  18. 6.3.5 Cytiva Recent Developments
  19. 6.4 Inside Therapeutics
  20. 6.4.1 Inside Therapeutics Company Information
  21. 6.4.2 Inside Therapeutics Business Overview
  22. 6.4.3 Inside Therapeutics Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Inside Therapeutics Nanomedicine Manufacturing Services Product Portfolio
  24. 6.4.5 Inside Therapeutics Recent Developments
  25. 6.5 Fortis Life Sciences
  26. 6.5.1 Fortis Life Sciences Company Information
  27. 6.5.2 Fortis Life Sciences Business Overview
  28. 6.5.3 Fortis Life Sciences Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Fortis Life Sciences Nanomedicine Manufacturing Services Product Portfolio
  30. 6.5.5 Fortis Life Sciences Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Nanomedicine Manufacturing Services Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Ascendia Pharmaceuticals
  38. 6.7.1 Ascendia Pharmaceuticals Company Information
  39. 6.7.2 Ascendia Pharmaceuticals Business Overview
  40. 6.7.3 Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Product Portfolio
  42. 6.7.5 Ascendia Pharmaceuticals Recent Developments
  43. 6.8 Axolabs
  44. 6.8.1 Axolabs Company Information
  45. 6.8.2 Axolabs Business Overview
  46. 6.8.3 Axolabs Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Axolabs Nanomedicine Manufacturing Services Product Portfolio
  48. 6.8.5 Axolabs Recent Developments
  49. 6.9 AVANSA Technology & Services
  50. 6.9.1 AVANSA Technology & Services Company Information
  51. 6.9.2 AVANSA Technology & Services Business Overview
  52. 6.9.3 AVANSA Technology & Services Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 AVANSA Technology & Services Nanomedicine Manufacturing Services Product Portfolio
  54. 6.9.5 AVANSA Technology & Services Recent Developments
  55. 6.10 MyBiotech
  56. 6.10.1 MyBiotech Company Information
  57. 6.10.2 MyBiotech Business Overview
  58. 6.10.3 MyBiotech Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 MyBiotech Nanomedicine Manufacturing Services Product Portfolio
  60. 6.10.5 MyBiotech Recent Developments
  61. 6.11 Nanochemazone
  62. 6.11.1 Nanochemazone Company Information
  63. 6.11.2 Nanochemazone Business Overview
  64. 6.11.3 Nanochemazone Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Nanochemazone Nanomedicine Manufacturing Services Product Portfolio
  66. 6.11.5 Nanochemazone Recent Developments
  67. 6.12 TechNanoIndia
  68. 6.12.1 TechNanoIndia Company Information
  69. 6.12.2 TechNanoIndia Business Overview
  70. 6.12.3 TechNanoIndia Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 TechNanoIndia Nanomedicine Manufacturing Services Product Portfolio
  72. 6.12.5 TechNanoIndia Recent Developments
  73. 6.13 Encapsula NanoSciences
  74. 6.13.1 Encapsula NanoSciences Company Information
  75. 6.13.2 Encapsula NanoSciences Business Overview
  76. 6.13.3 Encapsula NanoSciences Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Encapsula NanoSciences Nanomedicine Manufacturing Services Product Portfolio
  78. 6.13.5 Encapsula NanoSciences Recent Developments
  79. 6.14 STA Pharmaceutical Co. Ltd.
  80. 6.14.1 STA Pharmaceutical Co. Ltd. Company Information
  81. 6.14.2 STA Pharmaceutical Co. Ltd. Business Overview
  82. 6.14.3 STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Product Portfolio
  84. 6.14.5 STA Pharmaceutical Co. Ltd. Recent Developments
7 North America
  1. 7.1 North America Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
  3. 7.3 North America Nanomedicine Manufacturing Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
  3. 8.3 Europe Nanomedicine Manufacturing Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Nanomedicine Manufacturing Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
  3. 10.3 South America Nanomedicine Manufacturing Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Nanomedicine Manufacturing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Nanomedicine Manufacturing Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst